At the time of writing, Zimmer Biomet Holdings Inc [ZBH] stock is trading at $109.57, up 2.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZBH shares have lost -1.62% over the last week, with a monthly amount glided 2.99%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on July 01, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $115 from $140. Previously, Goldman started tracking the stock with Neutral rating on May 30, 2024, and set its price target to $129. On May 21, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $150 on the stock. Evercore ISI downgraded its rating to a In-line and decreased its price target to $125 on January 04, 2024. ROTH MKM initiated its recommendation with a Neutral and recommended $120 as its price target on October 20, 2023. BTIG Research upgraded its rating to Buy for this stock on August 28, 2023, but kept the price target unchanged to $139. In a note dated May 03, 2023, BofA Securities upgraded an Neutral rating on this stock.
For the past year, the stock price of Zimmer Biomet Holdings Inc fluctuated between $102.00 and $133.90. Currently, Wall Street analysts expect the stock to reach $140.77 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $109.57 at the most recent close of the market. An investor can expect a potential return of 28.47% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
According to Zimmer Biomet Holdings Inc [NYSE:ZBH], the company’s sales were 7.45B for trailing twelve months, which represents an 3.18% jump. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.08 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 107.38 points at the first support level, and at 105.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 111.33, and for the 2nd resistance point, it is at 113.09.
Ratios To Look Out For
It is important to note that Zimmer Biomet Holdings Inc [NYSE:ZBH] has a current ratio of 1.66. Further, the Quick Ratio stands at 0.80, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 3.02, the price to book ratio is 1.79 and price to earnings (TTM) ratio is 23.72.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on May 31 ’24 when 12857.0 shares were sold. Group President, Asia Pacific, Yi Sang completed a deal on Mar 07 ’24 to sell 1705.0 shares. Meanwhile, Sr. VP/Gen Counsel/Secretary Phipps Chad F sold 26156.0 shares on Feb 22 ’24.
